Description
(±)-MDA-d3 (hydro chloride) (exempt preparation)
(±)-MDA-d3 (hydrochloride) (exempt preparation) (Item No. 22875) is an analytical reference standard intended for use as an internal standard for the quantification of (±)-MDA (Item Nos. ISO60189 | 11554) by GC- or LC-MS. (±)-MDA is categorized as an amphetamine.1,2 It induces the head-twitch response (HTR) in mice, indicating hallucinogenic potential.2 (±)-MDA has been found in seized ecstasy tablets.3 (±)-MDA-d3 is regulated as a Schedule I compound in the United States. (±)-MDA-d3 (hydrochloride) (exempt preparation) (Item No. 22875) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
WARNING This product is not for human or veterinary use.
Synonyms
- 3,4-MDA-d3
- 3,4-Methylenedioxyamphetamine-d3
Technical Information
Formal Name
α-methyl-d3-1,3-benzodioxole-5-ethanamine, monohydrochloride
CAS Number
2747917-68-4
Molecular Formula
C10H10D3NO2 • HCl
Formula Weight
218.7
Purity
≥99% deuterated forms (d1-d3)
Formulation(Request formulation change)
A 1 mg/ml solution in methanol
λmax
237, 288 nm
SMILES
NC(C([2H])([2H])[2H])CC1=CC(OCO2)=C2C=C1.Cl
InChi Code
InChI=1S/C10H13NO2.ClH/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9;/h2-3,5,7H,4,6,11H2,1H3;1H/i1D3;
InChi Key
XLAOKZDOZHZWBK-NIIDSAIPSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Stability
≥ 2 years